Charles River Laboratories International Operating Income 2011-2026 | CRL

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Charles River Laboratories International

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
25.2 M	227 M	617 M	651 M	590 M	433 M	351 M	331 M	288 M	238 M	206 M	178 M	151 M	166 M	174 M	-299 M	170 M	-452 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
651 M	-452 M	225 M

Quarterly Operating Income Charles River Laboratories International

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1	2010-Q3	2010-Q2
120 M	134 M	100 M	74.7 M	-	117 M	152 M	126 M	-	152 M	165 M	168 M	-	151 M	187 M	149 M	-	156 M	138 M	124 M	129 M	133 M	76.8 M	94.3 M	109 M	92.8 M	79.8 M	69.8 M	102 M	84.4 M	76.7 M	67.8 M	62.8 M	74.1 M	81.7 M	69.7 M	69.1 M	58.8 M	58.1 M	51.5 M	52.3 M	55.4 M	55.7 M	43 M	40.8 M	46.2 M	51 M	39.7 M	24.6 M	40.8 M	43.2 M	42.8 M	-	37.7 M	49.3 M	43.7 M	-	37.1 M	53.3 M	42.3 M	5.11 M	28.2 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
187 M	5.11 M	83.7 M

Operating Income of other stocks in the Diagnostics research industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-46 M	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	-20.3 M	-	-	$ 1.31 B	USA
Agilent Technologies A	1.35 B	$ 114.96	0.15 %	$ 34.9 B	USA
Celcuity CELC	-172 M	$ 138.23	-3.02 %	$ 6.46 B	USA
Akumin AKU	-28.1 M	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	-50.2 M	$ 5.07	36.66 %	$ 6.74 M	USA
Castle Biosciences CSTL	-42.8 M	$ 20.15	-1.9 %	$ 584 M	USA
Aspira Women's Health AWH	-7.91 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-35.3 M	-	-61.36 %	$ 2.46 M	USA
Fulgent Genetics FLGT	-91.1 M	$ 17.11	-1.55 %	$ 527 M	USA
Biocept BIOC	-32 M	-	-13.05 %	$ 7.29 M	USA
Guardant Health GH	-437 M	$ 118.95	0.8 %	$ 14.9 B	USA
CareDx, Inc CDNA	-30.8 M	$ 21.63	0.28 %	$ 1.15 B	USA
Chembio Diagnostics CEMI	-23.6 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	-2.37 M	-	-	$ 9.42 M	Israel
ICON Public Limited Company ICLR	1.1 B	$ 116.78	0.18 %	$ 9.63 B	Irlanda
HTG Molecular Diagnostics HTGM	-20.8 M	-	-20.0 %	$ 1.06 M	USA
Interpace Biosciences IDXG	4.08 M	$ 1.82	1.11 %	$ 8.05 M	USA
Illumina ILMN	-833 M	$ 144.41	-0.29 %	$ 23 B	USA
Global Cord Blood Corporation CO	609 M	-	-	$ 399 M	China
Lantheus Holdings LNTH	311 M	$ 103.0	9.03 %	$ 6.95 B	USA
Genetron Holdings Limited GTH	-518 M	-	0.12 %	$ 80.1 M	China
DermTech DMTK	-104 M	-	-11.32 %	$ 2.94 M	USA
Enzo Biochem ENZ	-12.4 M	-	-8.98 %	$ 14.8 K	USA
NeoGenomics NEO	-116 M	$ 9.23	1.32 %	$ 1.18 B	USA
Medpace Holdings MEDP	535 M	$ 432.8	0.63 %	$ 12.5 B	USA
National Research Corporation NRC	22.6 M	$ 19.08	0.21 %	$ 427 M	USA
Natera NTRA	-541 M	$ 203.19	-0.25 %	$ 20 B	USA
Exact Sciences Corporation EXAS	-206 M	-	-	$ 19.8 B	USA
Myriad Genetics MYGN	-387 M	$ 3.82	-2.3 %	$ 354 M	USA
Personalis PSNL	-88.1 M	$ 8.47	2.67 %	$ 756 M	USA
Koninklijke Philips N.V. PHG	1.42 B	$ 26.95	-0.74 %	$ 25.6 B	Niderland
Senseonics Holdings SENS	-68.3 M	$ 6.34	2.92 %	$ 265 M	USA
QIAGEN N.V. QGEN	466 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	9.41 M	-	-	$ 2.69 B	USA
Twist Bioscience Corporation TWST	-136 M	$ 60.57	2.95 %	$ 3.62 B	USA
Biomerica BMRA	-5.14 M	$ 2.49	2.05 %	$ 5.72 M	USA
Laboratory Corporation of America Holdings LH	1.38 B	$ 259.93	1.63 %	$ 21.6 B	USA
Thermo Fisher Scientific TMO	7.75 B	$ 448.28	-0.24 %	$ 169 B	USA
Trinity Biotech plc TRIB	-21.2 M	$ 0.6	-3.7 %	$ 216 M	Irlanda
Motus GI Holdings MOTS	-11.9 M	-	-34.28 %	$ 263 K	Israel
Waters Corporation WAT	271 M	$ 342.37	0.4 %	$ 20.4 B	USA
Neogen Corporation NEOG	-1.06 B	$ 8.9	0.45 %	$ 1.93 B	USA
Quest Diagnostics Incorporated DGX	1.56 B	$ 195.21	0.72 %	$ 21.7 B	USA